Literature DB >> 21659756

Pathology of human diabetic nephropathy.

Behzad Najafian, Charles E Alpers, Agnes B Fogo.   

Abstract

Diabetic nephropathy (DN) develops in a subset of diabetic patients, on average about 15 years after onset of metabolic abnormalities. The earliest lesions consist of thickened glomerular basement membranes (GBM), mild mesangial expansion, and arteriolar accumulation of hyaline. Mesangiolysis and exuberant mesangial repair then develop, ultimately resulting in marked increase in mesangial matrix. Established nephropathy is characterized by mesangial expansion which may be nodular, so-called Kimmelstiel-Wilson nodules, hyaline in both afferent and efferent arterioles, and markedly thickened GBM by electron microscopy. Podocyte loss may be a crucial contributor to this progressive sclerosis. There is a distinct predilection of segmental sclerosis to occur at the glomerulotubular junction in type 1 diabetic patients, which can lead to disruption of outflow from the glomerulus, resulting in so-called a tubular glomeruli. A recent classification of DN may be useful for categorizing stages of development of the diabetic lesions. Diabetic injury also affects the tubulointerstitium. Tubular basement membranes thicken in parallel to GBM. Early interstitial inflammation with predominantly mononuclear cells is followed by later increased interstitial fibrosis and tubular atrophy. Lesions in type 1 and type 2 diabetic patients share many similarities, with more severe vascular disease and heterogeneous lesions, perhaps reflecting older age and comorbid conditions such as hypertension, in the latter. Diabetic patients typically undergo diagnostic renal biopsies only when the clinical course is not typical for DN, and not surprisingly, a range of other lesions may then be present in addition to DN. DN also recurs or occurs de novo in the transplant, developing more quickly than in the native kidney. Efforts to develop rodent animal models that more completely capture these key features of human DN will allow advances to be made in understanding pathogenesis and targeting novel treatment.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21659756     DOI: 10.1159/000324942

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  76 in total

Review 1.  The pathobiology of diabetic vascular complications--cardiovascular and kidney disease.

Authors:  Stephen P Gray; Karin Jandeleit-Dahm
Journal:  J Mol Med (Berl)       Date:  2014-04-01       Impact factor: 4.599

2.  B7-1 Is Not Induced in Podocytes of Human and Experimental Diabetic Nephropathy.

Authors:  Elena Gagliardini; Rubina Novelli; Daniela Corna; Carlamaria Zoja; Barbara Ruggiero; Ariela Benigni; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

3.  Mitochondrial ROS deficiency and diabetic complications: AMP[K]-lifying the adaptation to hyperglycemia.

Authors:  Dwight A Towler
Journal:  J Clin Invest       Date:  2013-10-25       Impact factor: 14.808

Review 4.  Autophagy and kidney inflammation.

Authors:  Tomonori Kimura; Yoshitaka Isaka; Tamotsu Yoshimori
Journal:  Autophagy       Date:  2017-04-25       Impact factor: 16.016

Review 5.  Genetics of diabetic nephropathy: a long road of discovery.

Authors:  Amy Jayne McKnight; Seamus Duffy; Alexander P Maxwell
Journal:  Curr Diab Rep       Date:  2015-07       Impact factor: 4.810

Review 6.  The role of the podocyte in albumin filtration.

Authors:  Paul Thomas Brinkkoetter; Christina Ising; Thomas Benzing
Journal:  Nat Rev Nephrol       Date:  2013-04-23       Impact factor: 28.314

7.  Reversibility of structural and functional damage in a model of advanced diabetic nephropathy.

Authors:  Warangkana Pichaiwong; Kelly L Hudkins; Tomasz Wietecha; Tri Q Nguyen; Chiraporn Tachaudomdach; Wei Li; Bardia Askari; Takahisa Kobayashi; Kevin D O'Brien; Jeffrey W Pippin; Stuart J Shankland; Charles E Alpers
Journal:  J Am Soc Nephrol       Date:  2013-05-02       Impact factor: 10.121

8.  Renoprotective effects of C-peptide in the Dahl salt-sensitive rat.

Authors:  R Taylor Sawyer; Elizabeth R Flynn; Zachary M Hutchens; Jan M Williams; Michael R Garrett; Christine Maric-Bilkan
Journal:  Am J Physiol Renal Physiol       Date:  2012-07-18

9.  Diabetes-induced renal injury in rats is attenuated by suramin.

Authors:  Midhun C Korrapati; Brooke E Shaner; Benjamin A Neely; Joseph L Alge; John M Arthur; Rick G Schnellmann
Journal:  J Pharmacol Exp Ther       Date:  2012-06-26       Impact factor: 4.030

Review 10.  Diabetic kidney disease and the cardiorenal syndrome: old disease, new perspectives.

Authors:  Ankur Jindal; Mariana Garcia-Touza; Nidhi Jindal; Adam Whaley-Connell; James R Sowers
Journal:  Endocrinol Metab Clin North Am       Date:  2013-08-01       Impact factor: 4.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.